Type : Bid Notification
Due : 07 Jul, 2023 (10 months ago)
Posted : 11 months ago
Started : 06 Jun, 2023 (11 months ago)
Expected enrollment for this trial is expected to begin in June 2023. The Department of Defense (DOD) is funding and has established this posttraumatic stress disorder (PTSD) adaptive platform trial (APT). The team is now seeking interested partners to serve as the regulatory sponsor and holder of the existing Master Protocol Investigational New Drug (IND) application to the U.S.
